Enzyrich Biotech Solutions Profile
Key Indicators
- Authorised Capital ₹ 0.70 M
as on 12-07-2024
- Paid Up Capital ₹ 0.50 M
as on 12-07-2024
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 1127.56%
(FY 2020)
- Profit 926.68%
(FY 2020)
- Ebitda 744.94%
(FY 2020)
- Net Worth 77.37%
(FY 2020)
- Total Assets 353.81%
(FY 2020)
About Enzyrich Biotech Solutions
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.70 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Aniruddha Digraskar and Madhavi Digraskar serve as directors at the Company.
- CIN/LLPIN
U73200PN2018PTC178831
- Company No.
178831
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Sep 2018
- Date of AGM
26 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Ahmed Nagar, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Enzyrich Biotech Solutions?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aniruddha Digraskar  | Managing Director | 19-Sep-2018 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Madhavi Digraskar | Whole-Time Director | 19-Sep-2018 | Current |
Financial Performance and Corporate Structure Insights of Enzyrich Biotech Solutions.
Enzyrich Biotech Solutions Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 1127.56% increase. The company also saw a substantial improvement in profitability, with a 926.68% increase in profit. The company's net worth Soared by an impressive increase of 77.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Enzyrich Biotech Solutions?
Unlock access to Enzyrich Biotech Solutions's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Enzyrich Biotech Solutions?
Unlock and access historical data on people associated with Enzyrich Biotech Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Enzyrich Biotech Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Enzyrich Biotech Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
